Atlas Reserve Precious Metals Launches Transparent Gold IRA and Silver IRA Platform for Retirement Investors

Atlas Reserve Precious Metals LLC is a Wyoming-registered precious metals dealer focused on transparent pricing, physical delivery options, and secure depository storage for self-directed retirement investors. The company provides access to IRS-eligible bullion products, allocated storage solutions, and rollover support services for qualified retirement accounts, founded on the principle that

Read More

Niihara International Announces Launch of Corp. Website and SEC Qualification of Reg. A Offering

Niihara International, Inc. has launched a new corporate website and received SEC qualification of its Regulation A+ Tier 2 offering to support development and commercialization of therapies, including L‑glutamine for sickle cell disease and other unmet medical needs. Irvine, California, United States, 21st May 2026– Niihara International, Inc. (“Niihara International” or

Read More

Baiyunshan Hanfang Pharmaceutical Releases Technical Progress on Industrial High-Purity Lipid Raw Materials

This Enterprise Unveils Industrial High-Purity Lipid Raw Material Product Portfolio for Global Fine Chemical Clients Guangzhou, Guangdong, China, 21st May 2026 – Guangzhou Hanfang Pharmaceutical Company Limited. (a subsidiary of Guangzhou Pharmaceutical Holdings Limited) today announced updates to its industrial lipid raw material product portfolio and global service upgrades. The company’s

Read More

Turn Energy into Profit Gareth Evans’ Newly Released Book Urges Businesses to Build Their Own Energy Infrastructure

United States, 21st May 2026 – Renowned energy strategist and highly experienced business leader Gareth Evans has released his book, Powering Profits: Control Energy Costs, Build Resilience, and Gain a Lasting Competitive Advantage. The new book is an invaluable corporate leadership guide that offers a deep dive into how power systems work and

Read More

CytoMed Therapeutics Ltd — A Rising Star in Singapore’s Cancer Biotechnology Sector

In February 2026, The Wall Street Transcript published an exclusive interview with CytoMed Therapeutics Ltd (NASDAQ: GDTC) Chairman Choo Chee Kong. The interview covered the company’s technological approach, clinical trial progress, global strategic expansion — particularly in China and India — financing status, and deep insights into the global biotechnology industry.    1.

Read More